Wednesday, June 23, 2021 2:00:41 AM
https://otcshortreport.com/company/CYDY?index=mdmn&action=view#.U6o6Ktq9KSO
https://www.marketbeat.com/stocks/OTCMKTS/CYDY/short-interest/
It's expensive trying to "keep this puppy (CYDY) down."
And NO WONDER >>>>> GREAT LONG HAULER RESULTS!!
Should be fireworks, parades, speeches, and lots of hoopla
Not
funeral dirges
Of the 33.5 million US citizens that have contracted Covid-19, 10-30% (That's approx 3-10 million) will develop Long Haulers. Leronlimab appears far and away the perfect answer. It resolves around 18 out of 24 symptoms, and those it doesn't help - there's no risk of serious hurt!
I like how Dr. Recknor acknowledged there was one leronlimab recipient that did not show improvement. Exploring this person's data will help illuminate factors that negate leronlimab's influence and define limitations. This will aid in future studies, possible "work-arounds" and/or delineate those who will have to seek alternate treatment.
Meanwhile
BP is calling in lots of favors to keep CYDY "frozen out." Now, BP can afford to do that - up to a point. Those "favors" can get costly and they DO add up. And those international favors can get really tacky. Also in the event of more than a "cursory" investigation - there will be some people "hanging out there."
For this reason, BP're trying to bring this CytoDyn thing to closure. They can only throw so much money, call in so many favors, make so many "deals," before something goes hinkey and this money/influence machine powerhouse they're created is "called out!"
I question the "rescue crew" that's being sent to rescue us from Blankety, blankety, blank Darth Nader! Lot of BUZZ being created for them. Really suspicious timing and corresponds nicely with the point of the preceding paragraph. Time for closure - send in the __________s.
Well, the bottom line >> Long Haulers was a Serious Success and there's more good stuff coming! I'm also liking the addition of "low-key, but SMART Dr. Recknor. Concrete objectives stated...
Now >>>>>> HIT those objectives
before happy the clown rides in on a unicycle
and off with chairmanship of the board.
IMO
Recent CYDY News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:01:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:01:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 10:15:19 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM